BioCentury | Jul 11, 2013
Translation in Brief

Translational tidbits

...new collaboration with Icahn School of Medicine to investigate triggers of inflammatory bowel disease (IBD) Latitude Pharmaceuticals Inc./Xeris...
BioCentury | Jul 1, 2013
Company News

Latitude Pharmaceuticals, Xeris, Juvenile Diabetes Research Foundation International (JDRF) deal

...JDRF and Xeris declined to disclose details, and Latitude could not be reached for comment. Latitude Pharmaceuticals Inc....
BioCentury | Jul 27, 2009
Company News

Latitude Pharmaceuticals deal

...release of small molecule and biological therapeutics via a phospholipid gel. Financial terms are undisclosed. Latitude Pharmaceuticals Inc....
Items per page:
1 - 3 of 3
BioCentury | Jul 11, 2013
Translation in Brief

Translational tidbits

...new collaboration with Icahn School of Medicine to investigate triggers of inflammatory bowel disease (IBD) Latitude Pharmaceuticals Inc./Xeris...
BioCentury | Jul 1, 2013
Company News

Latitude Pharmaceuticals, Xeris, Juvenile Diabetes Research Foundation International (JDRF) deal

...JDRF and Xeris declined to disclose details, and Latitude could not be reached for comment. Latitude Pharmaceuticals Inc....
BioCentury | Jul 27, 2009
Company News

Latitude Pharmaceuticals deal

...release of small molecule and biological therapeutics via a phospholipid gel. Financial terms are undisclosed. Latitude Pharmaceuticals Inc....
Items per page:
1 - 3 of 3